Page 19 - GTM-1-2

Global Translational Medicine Effect of leptin on aortic dissection

leptin and IL6: Association with silent myocardial ischemia ketoacidosis. Diabetologia, 59: 933–937.
in Type 2 diabetes mellitus. Diab Vasc Dis Res, 10: 25–31.
https://doi.org/10.1007/s00125-016-3909-4
https://doi.org/10.1177/1479164112440815
60. Feijoo-Bandin S, Portoles M, Rosello-Lleti E, et al., 2015,
50. Yamazaki Y, Emoto M, Morioka T, et al., 2013, Clinical 20 years of leptin: Role of leptin in cardiomyocyte physiology
impact of the leptin to soluble leptin receptor ratio on and physiopathology. Life Sci, 140: 10–18.
subclinical carotid atherosclerosis in patients with Type 2 https://doi.org/10.1016/j.lfs.2015.02.016
diabetes. J Atheroscler Thromb, 20: 186–194.
61. Gruzdeva OV, Akbasheva OE, Dyleva YA, et al., 2017,
https://doi.org/10.5551/jat.14662 Adipokine and cytokine profiles of epicardial and
51. Liu X, Li X, Li C, et al., 2019, Study on regulation of subcutaneous adipose tissue in patients with coronary heart
adipokines on body fat distribution and its correlation with disease. Bull Exp Biol Med, 163: 608–611.
metabolic syndrome in Type 2 diabetes mellitus. Minerva https://doi.org/10.1007/s10517-017-3860-5
Endocrinol, 44: 259–263.
62. Basati G, Razavi AE, Abdi S, et al., Association between
https://doi.org/10.23736/s0391-1977.17.02773-0 adipokine and myeloperoxidase levels in patients with
52. Asakawa H, Tokunaga K, Kawakami F. 2001, Relationship coronary artery disease. Acta Med Iran, 53: 25–29.
of leptin level with metabolic disorders and hypertension 63. Lodh M, Goswami B, Parida A, et al., 2012, Assessment of
in Japanese Type 2 diabetes mellitus patients. J Diabetes serum leptin, pregnancy-associated plasma protein A and
Complications, 15: 57–62. CRP levels as indicators of plaque vulnerability in patients
https://doi.org/10.1016/s1056-8727(00)00145-8 with acute coronary syndrome. Cardiovasc J Afr, 23: 330–335.
53. Morioka T, Emoto M, Yamazaki Y, et al., 2014, Leptin is https://doi.org/10.5830/CVJA-2012-008
associated with vascular endothelial function in overweight 64. Karatela RA, Sainani GS. 2010, Interrelationships of factor
patients with Type 2 diabetes. Cardiovasc Diabetol, 13: 10. VII activity and plasma leptin with insulin resistance in
https://doi.org/10.1186/1475-2840-13-10 coronary heart disease. Atherosclerosis, 209: 235–240.
54. Iraklianou S, Melidonis A, Tournis S, et al., 2001, Postprandial https://doi.org/10.1016/j.atherosclerosis.2009.08.043
leptin responses after an oral fat tolerance test: Differences 65. Gormez S, Demirkan A, Atalar F, et al., 2011, Adipose tissue
in Type 2 diabetes. Diabetes Care, 24: 1299–1301. gene expression of adiponectin, tumor necrosis factor-α and
https://doi.org/10.2337/diacare.24.7.1299-a leptin in metabolic syndrome patients with coronary artery
disease. Intern Med, 50: 805–810.
55. Zhang L, Qin Y, Liang D, et al., 2018, Association of
polymorphisms in LEPR with Type 2 diabetes and related https://doi.org/10.2169/internalmedicine.50.4753
metabolic traits in a Chinese population. Lipids Health Dis, 66. Bigalke B, Stellos K, Geisler T, et al., 2010, High plasma levels
17: 2. of adipocytokines are associated with platelet activation in
https://doi.org/10.1186/s12944-017-0644-x patients with coronary artery disease. Platelets, 21: 11–19.
56. Motawi T, Salman T, Shaker O, et al., 2015, Association of https://doi.org/10.3109/09537100903377584
polymorphism in adiponectin (+45 T/G) and leptin (-2548 67. Parhami F, Tintut Y, Ballard A, et al., 2001, Leptin enhances
G/A) genes with Type 2 diabetes mellitus in male Egyptians. the calcification of vascular cells: Artery wall as a target of
Arch Med Sci, 11: 937–944. leptin. Circ Res, 88: 954–960.
https://doi.org/10.5114/aoms.2015.54848 https://doi.org/10.1161/hh0901.090975

57. Su S, Zhang C, Zhang F, et al., 2016, The association between 68. Cirillo P, Angri V, De Rosa S, et al., 2010, Proatherothrombotic
leptin receptor gene polymorphisms and Type 2 diabetes effects of leptin in human coronary endothelial cells. Thromb
mellitus: A systematic review and meta-analysis. Diabetes Haemost, 103: 1065–1075.
Res Clin Pract, 121: 49–58.
https://doi.org/10.1160/TH09-06-0392
https://doi.org/10.1016/j.diabres.2016.08.008
69. Ikmal SI, Huri H, Vethakkan SR, et al., 2013, Potential
58. Yang MM, Wang J, Fan JJ, et al., 2016, Variations in the biomarkers of insulin resistance and atherosclerosis in
obesity gene “LEPR” contribute to risk of Type 2 diabetes Type 2 diabetes mellitus patients with coronary artery
mellitus: Evidence from a meta-analysis. J Diabetes Res, disease. Int J Endocrinol, 2013: 698567.
2016: 5412084.
https://doi.org/10.1155/2013/698567
https://doi.org/10.1155/2016/5412084
70. Sainani GS, Karatela RA. 2009, Plasma leptin in insulin-
59. Perry RJ, Petersen KF, Shulman GI. 2016, Pleotropic resistant and insulin-nonresistant coronary artery disease
effects of leptin to reverse insulin resistance and diabetic and its association with cardio-metabolic risk factors among

Volume 1 Issue 2 (2022) 11 https://doi.org/10.36922/gtm.v1i2.85